168 related articles for article (PubMed ID: 34253709)
1. Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis.
Chava S; Bugide S; Edwards YJK; Gupta R
Oncogenesis; 2021 Jul; 10(7):48. PubMed ID: 34253709
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer.
Zhang X; Liu D; Li M; Cao C; Wan D; Xi B; Li W; Tan J; Wang J; Wu Z; Ma D; Gao Q
J Hematol Oncol; 2017 Jan; 10(1):29. PubMed ID: 28114995
[TBL] [Abstract][Full Text] [Related]
3. Depletion of H3K79 methyltransferase Dot1L promotes cell invasion and cancer stem-like cell property in ovarian cancer.
Wang X; Wang H; Xu B; Jiang D; Huang S; Yu H; Wu Z; Wu Q
Am J Transl Res; 2019; 11(2):1145-1153. PubMed ID: 30899413
[TBL] [Abstract][Full Text] [Related]
4. The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription.
Wong M; Tee AEL; Milazzo G; Bell JL; Poulos RC; Atmadibrata B; Sun Y; Jing D; Ho N; Ling D; Liu PY; Zhang XD; Hüttelmaier S; Wong JWH; Wang J; Polly P; Perini G; Scarlett CJ; Liu T
Cancer Res; 2017 May; 77(9):2522-2533. PubMed ID: 28209620
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Histone Methyltransferase Disruptor of Telomeric Silencing 1-Like Restricts Avian Leukosis Virus Subgroup J Replication by Restoring the Innate Immune Response in Chicken Macrophages.
Chen S; Wang D; Liu Y; Zhao R; Wu T; Hu X; Pan Z; Cui H
Front Microbiol; 2020; 11():603131. PubMed ID: 33363525
[TBL] [Abstract][Full Text] [Related]
6. Targeting Histone Methyltransferase DOT1L by a Novel Psammaplin A Analog Inhibits Growth and Metastasis of Triple-Negative Breast Cancer.
Byun WS; Kim WK; Han HJ; Chung HJ; Jang K; Kim HS; Kim S; Kim D; Bae ES; Park S; Lee J; Park HG; Lee SK
Mol Ther Oncolytics; 2019 Dec; 15():140-152. PubMed ID: 31720371
[TBL] [Abstract][Full Text] [Related]
7. The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells.
Salvati A; Gigantino V; Nassa G; Giurato G; Alexandrova E; Rizzo F; Tarallo R; Weisz A
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31689915
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of DOT1L by Half-Selenopsammaplin A Analogs Suppresses Tumor Growth and EMT-Mediated Metastasis in Triple-Negative Breast Cancer.
Byun WS; Lee GH; Park HG; Lee SK
Pharmaceuticals (Basel); 2020 Dec; 14(1):. PubMed ID: 33379275
[TBL] [Abstract][Full Text] [Related]
9. Disruptor of telomeric silencing 1-like (DOT1L): disclosing a new class of non-nucleoside inhibitors by means of ligand-based and structure-based approaches.
Sabatino M; Rotili D; Patsilinakos A; Forgione M; Tomaselli D; Alby F; Arimondo PB; Mai A; Ragno R
J Comput Aided Mol Des; 2018 Mar; 32(3):435-458. PubMed ID: 29335872
[TBL] [Abstract][Full Text] [Related]
10. The Role of DOT1L in Normal and Malignant Hematopoiesis.
Arnold O; Barbosa K; Deshpande AJ; Zhu N
Front Cell Dev Biol; 2022; 10():917125. PubMed ID: 35712672
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer.
Alexandrova E; Lamberti J; Memoli D; Quercia C; Melone V; Rizzo F; Tarallo R; Giurato G; Nassa G; Weisz A
Cancer Cell Int; 2022 Nov; 22(1):336. PubMed ID: 36333801
[TBL] [Abstract][Full Text] [Related]
12. Differential Methylation of H3K79 Reveals DOT1L Target Genes and Function in the Cerebellum In Vivo.
Bovio PP; Franz H; Heidrich S; Rauleac T; Kilpert F; Manke T; Vogel T
Mol Neurobiol; 2019 Jun; 56(6):4273-4287. PubMed ID: 30302725
[TBL] [Abstract][Full Text] [Related]
13. The role of DOT1L in the proliferation and prognosis of gastric cancer.
Song Z; Wei Z; Wang Q; Zhang X; Tao X; Wu N; Liu X; Qian J
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31939604
[TBL] [Abstract][Full Text] [Related]
14. New Potent DOT1L Inhibitors for
Stauffer F; Weiss A; Scheufler C; Möbitz H; Ragot C; Beyer KS; Calkins K; Guthy D; Kiffe M; Van Eerdenbrugh B; Tiedt R; Gaul C
ACS Med Chem Lett; 2019 Dec; 10(12):1655-1660. PubMed ID: 31857842
[TBL] [Abstract][Full Text] [Related]
15. DOT1L promotes cell proliferation and invasion by epigenetically regulating STAT5B in renal cell carcinoma.
Hou Y; Huang S; Liu J; Wang L; Yuan Y; Liu H; Weng X; Chen Z; Hu J; Liu X
Am J Cancer Res; 2023; 13(1):276-292. PubMed ID: 36777512
[TBL] [Abstract][Full Text] [Related]
16. Histone Methyltransferase DOT1L is Involved in Larval Molting and Second Stage Nymphal Feeding in
Gobl J; Kumar Sinha D; Sima R; Perner J; Kopáček P; Valdés JJ; Rego ROM; Cabezas-Cruz A
Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32244625
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic drug library screening reveals targeting DOT1L abrogates NAD
Gu X; Hua Y; Yu J; Yang L; Ge S; Jia R; Chai P; Zhuang A; Fan X
J Pharm Anal; 2023 Jan; 13(1):24-38. PubMed ID: 36820078
[TBL] [Abstract][Full Text] [Related]
18. The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness.
Kari V; Raul SK; Henck JM; Kitz J; Kramer F; Kosinsky RL; Übelmesser N; Mansour WY; Eggert J; Spitzner M; Najafova Z; Bastians H; Grade M; Gaedcke J; Wegwitz F; Johnsen SA
Clin Epigenetics; 2019 Jan; 11(1):4. PubMed ID: 30616689
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Novel Disruptor of Silencing Telomeric 1-Like (DOT1L) Inhibitors using a Target-Specific Scoring Function for the (S)-Adenosyl-l-methionine (SAM)-Dependent Methyltransferase Family.
Wang Y; Li L; Zhang B; Xing J; Chen S; Wan W; Song Y; Jiang H; Jiang H; Luo C; Zheng M
J Med Chem; 2017 Mar; 60(5):2026-2036. PubMed ID: 28165739
[TBL] [Abstract][Full Text] [Related]
20. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.
Chen CW; Koche RP; Sinha AU; Deshpande AJ; Zhu N; Eng R; Doench JG; Xu H; Chu SH; Qi J; Wang X; Delaney C; Bernt KM; Root DE; Hahn WC; Bradner JE; Armstrong SA
Nat Med; 2015 Apr; 21(4):335-43. PubMed ID: 25822366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
